Abstract:A simple extraction followed by an LC‐MS/MS method is presented to effectively screen for pregabalin and metformin, in addition to more than 150 other compounds of interest in equine and canine urines. The prevalence of pregabalin and metformin in race‐day urine samples in Western Australia was monitored using this method over 12 months. More than 4000 equine and canine urine samples were screened, and four samples were confirmed positive for these substances. Positive identification and reporting of therapeutic substances intended for human consumption in race‐day equine and canine samples is a controversial topic. While inadvertent environmental exposure is a potential cause for the presence of these substances in race‐day samples, intentional use cannot be ruled out given their therapeutic benefits. Pregabalin is widely prescribed in Australia to treat epilepsy, anxiety, and neuropathic pain in humans; however, it is also increasingly used as a recreational drug. Metformin is commonly used to treat type 2 diabetes in humans. Both pregabalin and metformin have no routine use on racing animals and should not be present in race‐day samples taken from healthy animals. They are prohibited substances under the Rules of Racing with no established screening limits. Although therapeutic levels for these substances have been established in humans, such information is not available for animals. Pregabalin and metformin are analytically challenging molecules, more so when they are extracted from biological matrices routinely screened for hundreds of other compounds simultaneously. A simple extraction, followed by a targeted Ultra High‐Pressure Liquid Chromatography OrbitrapTM Mass Spectrometry method utilising a reverse‐phase C18 column, is presented. This method is effective in screening for pregabalin and metformin, in addition to more than 150 other compounds of interest in equine and canine urines. The prevalence of pregabalin and metformin in race‐day equine and canine urine samples in Western Australia was monitored using this method over 12 months. More than 4000 urine samples were screened, and four samples were confirmed positive for these substances.

Association of Official Racing Chemists guidelines for drug testing in animal hair for doping control

Analytical advances in horseracing medication and doping control from 2018 to 2023

Probing the hair detectability of prohibited substances in sports: an in vivo-in silico-clinical approach and analytical implications compared with plasma, urine, and faeces

Detection of FG‐4592 and metabolites in equine plasma, urine and hair following oral administration

Doping control analysis of myo‐inositol trispyrophosphate and 10 bisphosphonates in equine plasma by ion chromatography–mass spectrometry and its application to clodronic acid horse administration

Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography-high-resolution mass spectrometry (LC-HRMS)

Emerging Human Medications in Racing Animals: Analytical and Regulatory Challenges

PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry

A Broad-Spectrum Peptide Screening Method Using an Optimized Solid-Phase Extraction and Liquid Chromatography–High-Field Asymmetric Ion Mobility Spectrometry–Mass Spectrometry for Doping Control in Equine Urine

Confirmation of ethanol administration in racing greyhounds by LC‐MS‐MS

A steroidomic approach for biomarkers discovery in doping control

Analytical challenges in sports drug testing

Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry

Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti-doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been established

Annual banned-substance review: analytical approaches in human sports drug testing.

Detection of nonsteroidal and steroidal selective androgen receptor modulators in equine hair after oral administrations

Metabolic Pathway of Osilodrostat in Equine Urine Established through High-resolution Mass Spectrometric Characterization for Doping Control

Analytical techniques for screening of cannabis and derivatives from human hair specimens

Advances in SARMs anti‐doping analysis

Method Development and Validation for Simultaneous Detection of Corticosteroids, Small Peptides, SARMs and Quaternary Ammonium Drugs in Camel Urine for Doping Control Applications